Preoperative (neoadjuvant) systemic treatment of breast cancer, The Breast, vol.14, issue.6, pp.576-81, 2005. ,
DOI : 10.1016/j.breast.2005.08.010
Measuring response in a post-RECIST world: from black and white to shades of grey, Nature Reviews Cancer, vol.23, issue.5, pp.409-423, 2006. ,
DOI : 10.1038/nrc1883
Prognostic significance of a combined clinicopathologic score for response to primary systemic therapy in locally advanced breast cancer, Oncology Reports, vol.14, pp.513-533, 2005. ,
DOI : 10.3892/or.14.2.513
The role of apoptosis in cancer development and treatment response, Nat Rev Cancer, vol.5, pp.231-238, 2005. ,
Cellular Senescence in Cancer and Aging, Cell, vol.130, issue.2, pp.223-256, 2007. ,
DOI : 10.1016/j.cell.2007.07.003
Telomere dysfunction and tumour suppression: the senescence connection, Nature Reviews Cancer, vol.21, issue.6, pp.450-458, 2008. ,
DOI : 10.1038/nrc2393
Living on a break: cellular senescence as a DNA-damage response, Nature Reviews Cancer, vol.67, issue.7, pp.512-534, 2008. ,
DOI : 10.1038/nrc2440
Unexpected Pieces to the Senescence Puzzle, Cell, vol.133, issue.6, pp.958-61, 2008. ,
DOI : 10.1016/j.cell.2008.05.027
p53 and disease: when the guardian angel fails, Cell Death and Differentiation, vol.280, issue.6, pp.1017-1043, 2006. ,
DOI : 10.1038/sj.cdd.4401913
A biomarker that identifies senescent human cells in culture and in aging skin in vivo., Proceedings of the National Academy of Sciences, vol.92, issue.20, pp.9363-9370, 1995. ,
DOI : 10.1073/pnas.92.20.9363
Tumor cell senescence in cancer treatment, Cancer Res, vol.63, pp.2705-2720, 2003. ,
Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts, Biochemical Journal, vol.347, issue.2, pp.543-51, 2000. ,
DOI : 10.1042/bj3470543
Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell, Biochemical Pharmacology, vol.68, issue.9, pp.1699-708, 2004. ,
DOI : 10.1016/j.bcp.2004.06.033
Cellular senescence bypass screen identifies new putative tumor suppressor genes, Oncogene, vol.16, issue.14, pp.1961-70, 2008. ,
DOI : 10.1038/sj.emboj.7600656
Many roads lead to oncogene-induced senescence, Oncogene, vol.14, issue.20, pp.2801-2810, 2008. ,
DOI : 10.1016/j.molcel.2007.05.034
Tumour biology: Senescence in premalignant tumours, Nature, vol.436, issue.7051, p.642, 2005. ,
DOI : 10.1038/436642a
Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging, Journal of Cellular Physiology, vol.15, issue.3, pp.567-574, 2007. ,
DOI : 10.1002/jcp.20919
DNA damage is able to induce senescence in tumor cells in vitro and in vivo, Cancer Res, vol.62, pp.1876-83, 2002. ,
Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction, Journal of Biological Chemistry, vol.277, issue.38, pp.35509-35524, 2002. ,
DOI : 10.1074/jbc.M205477200
Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy, The Lancet, vol.360, issue.9336, pp.852-856, 2002. ,
DOI : 10.1016/S0140-6736(02)09969-5
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen, PLo S Med, vol.4, p.90, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00700961
A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays, Clinical Cancer Research, vol.13, issue.13, pp.3989-98, 2007. ,
DOI : 10.1158/1078-0432.CCR-07-0078
A simple p53 functional assay for screening cell lines, blood, and tumors., Proceedings of the National Academy of Sciences, vol.92, issue.9, pp.3963-3970, 1995. ,
DOI : 10.1073/pnas.92.9.3963
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma, Clinical Cancer Research, vol.10, issue.16, pp.5367-74, 2004. ,
DOI : 10.1158/1078-0432.CCR-04-0220
Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents, Oncogene, vol.23, issue.39, pp.6548-58, 2004. ,
DOI : 10.1038/sj.onc.1207873
The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe, Oncogene, vol.23, issue.25, pp.4353-61, 2004. ,
DOI : 10.1038/sj.onc.1207573
Evidence that p53-Mediated Cell-Cycle-Arrest Inhibits Chemotherapeutic Treatment of Ovarian Carcinomas, PLoS ONE, vol.7, issue.5, p.441, 2007. ,
DOI : 10.1371/journal.pone.0000441.s002
Induction of p53 Up-Regulated Modulator of Apoptosis Messenger RNA by Chemotherapeutic Treatment of Locally Advanced Breast Cancer, Clinical Cancer Research, vol.11, issue.5, pp.1863-1869, 2005. ,
DOI : 10.1158/1078-0432.CCR-04-1372
Changes in allelic imbalances in locally advanced breast cancers after chemotherapy, British Journal of Cancer, vol.18, issue.8, pp.1157-1164, 2007. ,
DOI : 10.1038/sj.onc.1200812